Doğan Bayram

14PUBLICATIONS

40CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)HaematologyMedical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 16, 2026

Low muscle mass predicts poor response to neoadjuvant chemotherapy in advanced ovarian cancer.

|Dec 25, 2025

The Combined ALBI-FIB-4 Score for Prognostic Stratification in Hepatocellular Carcinoma: A Single Center Retrospective Study.

Doğan Bayram, Efe Cem Erdat, Sema Nur Özsan Çelebi

|Oct 29, 2025

Clinicopathologic Disease Characteristics and Their Association with Adjuvant Chemotherapy Outcomes in Pulmonary Large-Cell Carcinoma Patients with or Without Neuroendocrine Features.

Doğan Bayram, Oznur Bal, Efe Cem Erdat

|Oct 24, 2025

Comparison of the Efficacy of First-Line Pemetrexed-Platinum and Gemcitabine-Platinum Regimens in Malignant Peritoneal Mesothelioma.

Doğan Bayram, Safa Can Efil, Serap Türk

|Sep 27, 2025

The Impact of Clinical and Morphometric Parameters on Hematopoietic Engraftment Following High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Germ Cell Tumors.

Ömer Faruk Kuzu, Nuri Karadurmuş, Ahmet Gazi Acar

|Sep 03, 2025

Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study.

Ogur Karhan, Serdar İleri, Zuhat Urakçı

Pageof 3

Frequent Collaborators

Serhat Sekmek

Öznur Bal

Fahriye Tugba Kos

Perihan Perkin

Doğan Uncu

Emre Hafızoğlu

Murat Bardakçı

Irfan Karahan

Gökhan Uçar

Yakup Ergun

Frequent Collaborators

Serhat Sekmek

Öznur Bal

Fahriye Tugba Kos

Perihan Perkin